These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16426712)

  • 1. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice.
    Lee BH; Yoshimatsu K; Araki K; Okumura M; Nakamura I; Arikawa J
    Vaccine; 2006 Apr; 24(15):2928-34. PubMed ID: 16426712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test.
    Ogino M; Ebihara H; Lee BH; Araki K; Lundkvist A; Kawaoka Y; Yoshimatsu K; Arikawa J
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):154-60. PubMed ID: 12522053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.
    Brown KS; Safronetz D; Marzi A; Ebihara H; Feldmann H
    J Virol; 2011 Dec; 85(23):12781-91. PubMed ID: 21917979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.
    Majid AM; Ezelle H; Shah S; Barber GN
    J Virol; 2006 Jul; 80(14):6993-7008. PubMed ID: 16809305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.
    Braxton CL; Puckett SH; Mizel SB; Lyles DS
    J Virol; 2010 Apr; 84(7):3552-61. PubMed ID: 20089648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.
    Prescott J; DeBuysscher BL; Brown KS; Feldmann H
    Viruses; 2014 Jan; 6(2):516-23. PubMed ID: 24492621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adenovirus expressing vesicular stomatitis virus G proteins induce both humoral and cell-mediated immune responses in mice and goats.
    Xue X; Yu Z; Jin H; Liang L; Li J; Li X; Wang Y; Cui S; Li G
    BMC Vet Res; 2021 Jan; 17(1):36. PubMed ID: 33461549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
    Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
    Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01.
    Iyer AV; Pahar B; Boudreaux MJ; Wakamatsu N; Roy AF; Chouljenko VN; Baghian A; Apetrei C; Marx PA; Kousoulas KG
    Vaccine; 2009 Feb; 27(6):893-903. PubMed ID: 19070640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction.
    Bachmann MF; Hengartner H; Zinkernagel RM
    Med Microbiol Immunol; 1994 Dec; 183(6):315-24. PubMed ID: 7596314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors.
    Slough MM; Chandran K; Jangra RK
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice.
    Case JB; Rothlauf PW; Chen RE; Kafai NM; Fox JM; Smith BK; Shrihari S; McCune BT; Harvey IB; Keeler SP; Bloyet LM; Zhao H; Ma M; Adams LJ; Winkler ES; Holtzman MJ; Fremont DH; Whelan SPJ; Diamond MS
    Cell Host Microbe; 2020 Sep; 28(3):465-474.e4. PubMed ID: 32798445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector.
    Kapadia SU; Simon ID; Rose JK
    Virology; 2008 Jun; 376(1):165-72. PubMed ID: 18396306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters.
    Kamrud KI; Hooper JW; Elgh F; Schmaljohn CS
    Virology; 1999 Oct; 263(1):209-19. PubMed ID: 10544095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice.
    Yu L; Bai W; Wu X; Zhang L; Zhang L; Li P; Wang F; Liu Z; Zhang F; Xu Z
    Virol J; 2013 Oct; 10():301. PubMed ID: 24093752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice.
    Grigera PR; Marzocca MP; Capozzo AV; Buonocore L; Donis RO; Rose JK
    Virus Res; 2000 Aug; 69(1):3-15. PubMed ID: 10989181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host.
    Martinez I; Barrera JC; Rodriguez LL; Wertz GW
    Vaccine; 2004 Sep; 22(29-30):4035-43. PubMed ID: 15364454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy.
    Jiang DB; Zhang JP; Cheng LF; Zhang GW; Li Y; Li ZC; Lu ZH; Zhang ZX; Lu YC; Zheng LH; Zhang FL; Yang K
    Antiviral Res; 2018 Feb; 150():174-182. PubMed ID: 29273568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein.
    Jiang DB; Sun YJ; Cheng LF; Zhang GF; Dong C; Jin BQ; Song CJ; Ma Y; Zhang FL; Yang K
    Vaccine; 2015 Jun; 33(29):3367-76. PubMed ID: 26027907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.